Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Lorena Valero Arrese

Lorena Valero Arrese

Metgessa adjunta del servei d'Oncohematologia Pediàtrica.

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Doctor
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital
Lorena Valero Arrese

Lorena Valero Arrese

Lorena Valero Arrese

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Doctor
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital

Metgessa adjunta del servei d'Oncohematologia Pediàtrica.

Després de llicenciar-me en Medicina en la Universitat del País Basc, vaig realitzar la residència en Pediatria a l'Hospital Virgen de las Nieves de Granada, centrant el meu últim any de formació en el camp de l'oncohematologia. Des de 2017 formo part de l'equip d'Oncohematologia Pediàtrica de Vall d'Hebron, i les meves àrees d'especial interès són els assajos clínics en fase precoç i la histiocitosis de cèl·lules de Langerhans.

Projects

Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain, Miguel Segura Ginard, Lorena Valero Arrese, Raquel Hladun Alvaro, Elena Antima Martinez Saez, Marta Sese Faustino, Gabriela Guillén Burrieza, Josep Roma Castanyer, Andrea Vilaplana Blanes, Margarita Ortega Blanco, María Rosario Pérez- Torres Lobato, Asbleidy Carolina Torres Barbosa, Berta Campos Estela
Funding agency: Instituto de Salud Carlos III
Funding: 369260
Reference: PMP21/00073
Duration: 01/01/2022 - 31/12/2025

Next generation personalised medicine for childhood cancers

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Jessica Camacho Soriano, Raquel Hladun Alvaro, Gabriela Guillén Burrieza, Andrea Vilaplana Blanes, Lorena Valero Arrese, Mariona Morell Daniel
Funding agency: Instituto de Salud Carlos III
Funding: 214170
Reference: PI21/01661
Duration: 01/01/2022 - 30/06/2026

Related news

ERN-EuroBloodNet

Vall d'Hebron leads the analysis of COVID-19 in rare hematological diseases

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

Entrega xec Mi compañero de viaje

Mi Compañero de Viaje adds a decade of donations in the fight against cancer

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

Equip del grup de Càncer i Malalties Hematològiques Infantils del VHIR

A study demonstrates the effectiveness of gene therapy in patients with Fanconi anemia

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.

See more

Related professionals

Lluis Gabalda Martinez

Lluis Gabalda Martinez

Research technician
Molecular Medical Imaging
Read more
Montse Adell Trape

Montse Adell Trape

General Surgery
Read more
Eduard Argudo Serra

Eduard Argudo Serra

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Ferran Polo Torres

Ferran Polo Torres

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.